Article citationsMore>>

Fenouille, N., Tichet, M., Dufies, M., Pottier, A., Mogha, A., Soo, J.K., Rocchi, S., Mallavialle, A., Galibert, M.D., Khammari, A., Lacour, J.P., Ballotti, R., Deckert, M. and Tartare-Deckert, S. (2012) The Epithelial-Mesenchymal Transition (EMT) Regulatory Factor SLUG (SNAI2) Is a Downstream Target of SPARC and AKT in Promoting Melanoma Cell Invasion. PloS One, 7, 40378.
https://doi.org/10.1371/journal.pone.0040378

has been cited by the following article:

• TITLE: Myometrium and Sigmoid Colon Metastatic Melanoma Simulating a Ewing Tumor: A Case Report

  AUTHORS: Adjoby Cassou Roland, Kouame Arthur Didier, Alla Christian, Effoh N’Drin Denis, Konan Joachim, Aloui Adil, Andriamindimbison N. Zoly, Ahounkeng Patrick, Birembaut Philippe, Abboud Pascal

  KEYWORDS: Melanoma, Uterine Metastases, Myometrium, Ewing Tumor, PNET

  JOURNAL NAME: Open Journal of Obstetrics and Gynecology, Vol.7 No.8, August 15, 2017

  ABSTRACT: Malignant melanomas or lymphoma of the skin are malignant tumors of the skin and/or the mucous membranes whose uterine metastases are rare. The secondary uterine localizations, although rare, must be evoked in front of a pelvic tumoral syndrome, or diffuse metastases and a personal past history of melanoma, even after a long time of remission. In our observation, the evolution of the tumor in the pelvis extended to the muscular structures of the uterus and the sigmoid colon of a 72 year old patient, what made it an exceptional case. The diagnosis of these secondary localizations is a diagnosis of elimination, almost always post-operative, made on the histopathological and immunocytochemical study of the surgical specimen, supported by cytogenetics, even molecular biology. The treatment is based on chemotherapy.